According to the latest report published by Data Bridge Market Research, the Demyelinating Diseases Therapeutics Market  CAGR Value The global demyelinating diseases therapeutics market size was valued at USD 1.05 billion in 2025and is expected to reach USD 2.33 billion by 2033, at a CAGR of 10.50% during the forecast period To impart a supreme quality to this persuasive...

The Electroencephalography (EEG) Devices Market was valued at USD 1,414.25 million in 2024 and is projected to grow at a CAGR of 9.5% from 2025 to 2034, reaching USD 3,492.03 million by 2034. Growth is driven by advancements in wireless EEG devices, increasing prevalence of neurological disorders, and rising adoption of neurodiagnostic tools across hospitals, clinics,...

Executive Summary Guillain-Barré Syndrome (GBS) Market Size and Share Forecast The global Guillain-Barré Syndrome (GBS) market size was valued at USD 724.16 million in 2024 and is expected to reach USD 1.09 billion by 2032, at a CAGR of 5.30% during the forecast period. This Guillain-Barré Syndrome (GBS) Market research report is a...

Therapeutic plasma exchange (TPE) is an extracorporeal procedure of blood purification that is applied to treat patients with a range of conditions. TPE is a relatively common treatment modality nowadays. It shows positive clinical outcomes in the management of Guillain-Barré syndrome, thrombotic thrombocytopenic purpura (TTP), myasthenia gravis, and Goodpasture syndrome. The Therapeutic...